Press "esc" to clear
Go to Advanced Search

Showing results

110 of 628
170115_McQuade_J.jpg
  • Embargo expired:
    12-Feb-2018 6:30 PM EST

Article ID: 689338

Obesity Associated with Longer Survival for Men with Metastatic Melanoma

University of Texas M. D. Anderson Cancer Center

Obese patients with metastatic melanoma who are treated with targeted or immune therapies live significantly longer than those with a normal body mass index (BMI), investigators report in a study published in Lancet Oncology of 1,918 patients in six independent clinical cohorts. This effect, referred to as the “Obesity Paradox”, principally manifested itself in men, said Jennifer McQuade, M.D., lead author and instructor of Melanoma Medical Oncology at The University of Texas MD Anderson Cancer Center.

Released:
12-Feb-2018 8:05 AM EST
EXPERT AVAILABLE
Add to Favorites
Comment

Channels:

All Journal News, Cancer, Dermatology, Obesity, Local - Texas, Local - Houston Metro

LangFueyoGomez.jpg
  • Embargo expired:
    12-Feb-2018 4:00 PM EST

Article ID: 689348

Smart Bomb Virus Shows Promise as Brain Tumor Immunotherapy

University of Texas M. D. Anderson Cancer Center

A common cold virus engineered to attack the most common and deadly of brain tumors allowed 20 percent of patients with recurrent glioblastoma to live for three years or longer, researchers from The University of Texas MD Anderson Cancer Center report on a phase I clinical trial in the Journal of Clinical Oncology.

Released:
12-Feb-2018 10:05 AM EST
EXPERT AVAILABLE
Add to Favorites
Comment

Channels:

All Journal News, Cancer, Immunology, Neuro, Local - Texas, Local - Houston Metro

Hung_Mien_Chie2.jpg
  • Embargo expired:
    12-Feb-2018 12:00 PM EST

Article ID: 689298

Newly Identified Potential Therapeutic Approach Kills Triple-Negative Breast Cancer Cells in Pre-Clinical Study

University of Texas M. D. Anderson Cancer Center

Triple-negative breast cancer (TNBC), a highly aggressive, relapse-prone cancer that accounts for one-fourth of all breast cancers, could be the focus of a new area of study for immune checkpoint blockade therapy. A team of researchers at The University of Texas MD Anderson Cancer Center revealed that in TNBC a cell process called glycosylation is required for PD-L1/PD1 molecules to interact and identified exactly how and why glycosylation is so crucial.

Released:
9-Feb-2018 12:00 PM EST
EXPERT AVAILABLE
Add to Favorites
Comment

Channels:

All Journal News, Cancer, Cell Biology, Immunology, Women's Health, Local - Texas, Local - Houston Metro

Dr.-Higginscasualinwhitecoat-correctedweb.jpg

Article ID: 689279

UTHealth Leads ACSM Paper on Safety Recommendations for Energy Drinks

University of Texas Health Science Center at Houston

Helpful guidance and warnings regarding the potential dangers that energy drinks present to at-risk populations, primarily children, were published in a paper led by a cardiologist at The University of Texas Health Science Center at Houston (UTHealth) for the American College of Sports Medicine (ACSM).

Released:
8-Feb-2018 5:05 PM EST
EXPERT AVAILABLE
Add to Favorites
Comment

Channels:

All Journal News, Food Science, Nutrition, Sports, Sports Medicine, Local - Texas, Local - Houston Metro

henry_kuerer.jpg
  • Embargo expired:
    31-Jan-2018 11:00 AM EST

Article ID: 688660

MD Anderson Study Evaluates Need for Biopsies During Follow-Up Care in Women with Early Breast Cancer

University of Texas M. D. Anderson Cancer Center

In an analysis of more than 120,000 women diagnosed with and treated for early-stage breast cancer, researchers from The University of Texas MD Anderson Cancer Center determined the rate of additional breast biopsies needed for these patients during their follow-up care. The findings, reported in JAMA Surgery, are the first comprehensive nationwide population-based study regarding the need for breast biopsies performed during follow up after treatment for invasive breast cancer.

Released:
30-Jan-2018 11:00 AM EST
EXPERT AVAILABLE
Add to Favorites
Comment

Channels:

All Journal News, Cancer, Women's Health, JAMA, Local - Texas, Local - Houston Metro

SuarezMacGillivray1.jpg

Article ID: 688420

Houston Methodist Hospital Reaches Heart Transplant Milestone

Houston Methodist

Houston Methodist Hospital performed its 1000th heart transplant. The hospital's first was performed by Dr. Michael DeBakey in 1968 as part of the world's first multi-organ transplant. The patient is a 23-year old man who suffers from Becker's Muscular Dystrophy, a rare form of the disease that damages the heart.

Released:
24-Jan-2018 12:05 PM EST
EXPERT AVAILABLE
Add to Favorites
Comment

Channels:

Cardiovascular Health, Heart Disease, Surgery, Transplantation, Local - Texas, Local - Houston Metro

  • Embargo expired:
    17-Jan-2018 6:30 PM EST

Article ID: 687969

Presurgical Targeted Therapy Delays Relapse of High-Risk Stage 3 Melanoma

University of Texas M. D. Anderson Cancer Center

A pair of targeted therapies given before and after surgery for melanoma produced at least a six-fold increase in time to progression compared to standard-of-care surgery for patients with stage 3 disease, researchers at The University of Texas MD Anderson Cancer Center report in Lancet Oncology. Patients who had no sign of disease at surgery after combination treatment did not progress to metastasis.

Released:
16-Jan-2018 10:05 AM EST
EXPERT AVAILABLE
Add to Favorites
Comment

Channels:

Cancer, Dermatology, Surgery, Local - Texas, Local - Houston Metro

JimAllison.jpeg

Article ID: 688037

National Academy of Sciences Awards Kovalenko Medal to Immunotherapy Pioneer Allison

University of Texas M. D. Anderson Cancer Center

Cancer immunotherapy innovator Jim Allison, Ph.D., chair of Immunology at The University of Texas MD Anderson Cancer Center, will receive the 2018 Jessie Stevenson Kovalenko Medal for outstanding research in medical sciences, the National Academy of Sciences announced today.

Released:
17-Jan-2018 11:05 AM EST
EXPERT AVAILABLE
Add to Favorites
Comment

Channels:

Cancer, Infectious Diseases, Local - Texas, Local - Houston Metro

clyburn_microspheres_roomhome.jpg

Article ID: 687723

Tiny Antibiotic Beads Fight Infections After Joint Replacement

Houston Methodist

More than 1 million people undergo total joint replacements each year, and nearly 10,000 will develop infections. To reduce this infection risk, a Houston Methodist orthopedic surgeon created small antibiotic beads that are implanted with the new joint to slowly release medicine for several weeks.

Released:
9-Jan-2018 6:05 PM EST
EXPERT AVAILABLE
Add to Favorites
Comment
HCPCoutdoorspacecommunityservicesorkerwithpatient.jpg

Article ID: 687636

Plan for UTHealth Continuum of Care Campus for Behavioral Health Announced with State’s Approval of Initial Funds

University of Texas Health Science Center at Houston

With the first $6 million in state funds approved for the construction of a psychiatric hospital in Houston, UTHealth will oversee construction of a continuum of care campus for behavioral health that addresses a critical need in Texas.

Released:
8-Jan-2018 5:05 PM EST
EXPERT AVAILABLE
Add to Favorites
Comment

Showing results

110 of 628





Chat now!